Literature DB >> 1466248

A case of primary sarcoma of the pulmonary artery.

K Hiroshima1, T Uruma, M Ishibashi, H Ohwada, Y Hayashi.   

Abstract

A 39-year-old male was admitted complaining of nonproductive cough and dyspnea on exertion. Death occurred eight months after onset of the symptoms. Autopsy examination showed that the pulmonary trunk and left main pulmonary artery were markedly dilated and completely occluded by a tumor. The tumor had infiltrated into the left upper lobe and mediastinal lymph nodes, and metastatic nodules were found in both lungs and in the left adrenal gland. Small foci of infarction were noted in the lower lobes of both lungs. The tumor cells were of two types; pleomorphic spindle cells and bizarre multinucleated giant cells. Immunohistochemically, they were positive for vimentin, myosin, and lysozyme, but negative for desmin and muscle-specific actin. The cytoplasm of the tumor cells was showed by electron microscopy to contain microfilaments, dense bodies, and pinocytotic vesicles. We diagnosed this case as undifferentiated sarcoma of the pulmonary artery. Approximately 100 cases of pulmonary artery sarcoma have been reported. Histopathologically, almost all of the reported cases showed both spindle cells and pleomorphic giant cells, indicating a biologically anaplastic neoplasm.

Entities:  

Mesh:

Year:  1992        PMID: 1466248     DOI: 10.1111/j.1440-1827.1992.tb03227.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  2 in total

1.  Primary pulmonary artery sarcoma: a close associate of pulmonary embolism-20-year observational analysis.

Authors:  Debabrata Bandyopadhyay; Tanmay S Panchabhai; Navkaranbir S Bajaj; Pradnya D Patil; Matthew C Bunte
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 2.  Sarcoma of the pulmonary artery: report of four cases with electron microscopic and immunohistochemical examinations, and review of the literature.

Authors:  L Johansson; B Carlén
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.